Aptose to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

SAN DIEGO and TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, and the Aptose management team will participate at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit:

Click to view original post

Advertise With Us